While no direct evidence links HBV or HCV to brain pathology via CNS-initiated events, our findings suggest that systemic immunosuppression associated with these infections might indirectly influence neurodegeneration by modulating CD33+ cells – including microglia, peripheral myeloid cells and other CNS-resident macrophages. This evidence concerns the gene CD33 and infection.